BioNeMo
NVIDIA
End-to-end AI platform for drug discovery providing GPU-accelerated NIMs (NVIDIA Inference Microservices) spanning protein structure, molecular generation, docking, and property prediction. Includes ESMFold, DiffDock, MolMIM, and 25+ healthcare NIMs.
Best For
Enterprise-scale AI drug discovery pipelines; GPU-accelerated inference across multiple model types
License
Commercial (free tier for academic)
Strengths
- +25+ pre-trained NIMs
- +GPU-accelerated inference
- +Unified API across modalities
- +Adopted by top-20 pharma
Limitations
- −NVIDIA GPU lock-in
- −Commercial licensing for production
- −Models not fully open-source
R&D Pipeline Coverage
Related Tools
MolMIM
NVIDIA
Molecular generation model using Mutual Information Machine with a Perceiver encoder. Maps molecules into a smooth latent space enabling controlled interpolation and optimization.
DiffDock / DiffDock-L
MIT CSAIL (Corso et al.)
Diffusion-based generative model that treats docking as a generative problem over ligand poses. No pre-specified binding pocket needed.
ESMFold
Meta AI (FAIR)
Single-sequence protein structure prediction using the ESM-2 protein language model (15B parameters). No MSA required — fast inference directly from sequence.
Stay updated on BioNeMo
Weekly newsletter covering AI tool releases, benchmarks, and what practitioners actually use.